Company news
Alps Group Inc (NASDAQ:ALPS) news
Alps Group Inc news releases on 6ix. Latest, Aug 7, 2026: Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update
Press releases & updates
Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update
August 7, 2026
Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia
June 23, 2026
Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022
June 8, 2026
Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
May 18, 2026
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight
April 16, 2026
Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol
February 22, 2026
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
January 30, 2026
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
January 7, 2026
Alps Announces Closing of Business Combination with Globalink Investment Inc.
October 31, 2025